In 1991, Bryant and Eckard estimated the annual probability that a cartel would be detected by the US Federal authorities, conditional on being detected, to be at most between 13 % and 17 %. 15 years later, we estimated the same probability over a European sample and we found an annual...

This article surveys the empirical literature on how patents affect access to drugs in developing countries. In the short run, higher prices and lower access rates are very likely, notably for those countries that benefited from a competitive supply before the TRIPS agreement came into force....

Reformed under NAFTA negotiations and in compliance with the TRIPs Agreement (Trade Related Intellectual Property Rights) when Mexico joined the World Trade Organization, patent protection for pharmaceuticals in this country has been reinforced since 1991 with the new Industrial Property Law....

Based on a sample of 64 cartels convicted by the European Commission from 1975 to 2009 and a methodology allowing to estimate restitution and dissuasive fines to be imposed on cartels from microeconomic variables on a case by case basis, this paper compares the level of fines actually inflicted...

In 1991, Bryant and Eckard estimated the annual probability that a cartel would be detected by the US Federal authorities, conditional on being detected, to be at most between 13% and 17%. In this paper, we develop a general stochastic detection model so as to describe the dynamic that governs...

The aim of this thesis is to examine the competition patterns that exist between originators and generics by focusing on the articulations between regulation and incentives to innovate. Once the characteristics of regulation in pharmaceutical markets is reviewed in the first chapter and an...